Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,470.00    50.00 (2.07%)
Bid:
2,466.00
Ask:
2,470.00
Spread: 4.00 (0.162%)
Market Cap: £7.93b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Acquisition

23 Nov 2017 07:00

RNS Number : 2712X
Bunzl PLC
23 November 2017
 

23 November 2017

 

 

BUNZL COMPLETES ACQUISTION IN FRANCE AND ANNOUNCES FURTHER EXPANSION IN AUSTRALIA AND BRAZIL

 

Bunzl plc, the international distribution and outsourcing Group, today announces that the acquisition of Hedis, Comptoir de Bretagne and Générale Collectivités, that was announced on 20 July 2017, has been completed following clearance of the transaction by the French Competition Authority.

 

The Company has also recently acquired Interpath in Australia and entered into an agreement to acquire Talge in Brazil.

 

Interpath, which is based in Melbourne, is principally engaged in the distribution of a variety of laboratory and healthcare related consumable products to the pathology, medical research and life science end user markets in Australia. Customers include public and private hospitals and other pathology and research laboratories. Revenue in the year ended June 2017 was A$22 million (c.£13 million).

 

Talge, which is based in Santa Catarina, is principally engaged in the sale of a variety of foodservice related products, mainly to redistributors in the southeast region of Brazil. Revenue in the year ended December 2016 was R$83 million (c.£20 million). Completion of the acquisition is subject to clearance of the transaction by the Brazilian competition authority.

 

Commenting on the acquisitions, Frank van Zanten, Chief Executive of Bunzl said:

 

"I am delighted that we have now completed the purchase of Hedis, Comptoir de Bretagne and Générale Collectivités. Together these businesses further expand our existing cleaning & hygiene operations in France and extend our business there into the catering equipment sector for the first time.

 

The acquisition of Interpath has enhanced our healthcare business in Australia and extended our product offering into the pathology, medical research and life science markets there, while the proposed purchase of Talge will expand our operations into the foodservice sector in Brazil."

 

 

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive

Brian May, Finance Director

Tel: 020 7725 5000

Tulchan

David Allchurch

Martin Robinson

Tel: 020 7353 4200

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBTBATMBTTBTR
Date   Source Headline
1st Nov 201812:29 pmRNSBlock listing Interim Review
24th Oct 20183:30 pmRNSHolding(s) in Company
23rd Oct 20187:00 amRNSTrading Statement
16th Oct 20187:00 amRNSHolding(s) in Company
10th Oct 20185:36 pmRNSDirector/PDMR Shareholding
5th Oct 20183:15 pmRNSDirector/PDMR Shareholding
2nd Oct 20185:15 pmRNSDirector/PDMR Shareholding
1st Oct 201810:30 amRNSTotal Voting Rights
27th Sep 201811:27 amRNSDirector/PDMR Shareholding
4th Sep 20185:00 pmRNSDirector/PDMR Shareholding
4th Sep 20189:50 amRNSTotal Voting Rights
3rd Sep 20185:15 pmRNSDirector/PDMR Shareholding
29th Aug 20185:12 pmRNSDirector/PDMR Shareholding
29th Aug 20185:11 pmRNSDirector/PDMR Shareholding
29th Aug 20185:09 pmRNSDirector/PDMR Shareholding
28th Aug 20184:35 pmRNSDividend Declaration
28th Aug 20187:00 amRNSHalf-year Report
28th Aug 20187:00 amRNSAcquisition
1st Aug 20184:30 pmRNSTotal Voting Rights
13th Jul 201810:30 amRNSDirector/PDMR Shareholding
2nd Jul 201812:30 pmRNSTotal Voting Rights
27th Jun 20187:00 amRNSTrading Statement
1st Jun 201810:45 amRNSTotal Voting Rights
24th May 201812:30 pmRNSDirector/PDMR Shareholding
23rd May 20183:30 pmRNSDirector/PDMR Shareholding
23rd May 20181:00 pmRNSDirector/PDMR Shareholding
23rd May 201810:51 amRNSDirector Declaration
18th May 20188:00 amRNSAdditional Listing
10th May 20188:12 amRNSDirector/PDMR Shareholding
9th May 201812:00 pmRNSDirector/PDMR Shareholding
2nd May 201811:15 amRNSHolding(s) in Company
2nd May 201810:40 amRNSBlock listing Interim Review
2nd May 201810:30 amRNSDirector/PDMR Shareholding
2nd May 201810:08 amRNSTotal Voting Rights
30th Apr 201810:04 amRNSHolding(s) in Company
23rd Apr 20181:31 pmRNSDirector Declaration
19th Apr 20183:45 pmRNSDirector/PDMR Shareholding
18th Apr 20183:49 pmRNSResult of AGM
18th Apr 20187:00 amRNSTrading Statement
10th Apr 201812:10 pmRNSDirector/PDMR Shareholding
10th Apr 201812:00 pmRNSDirector/PDMR Shareholding
9th Apr 20184:20 pmRNSDirector/PDMR Shareholding
9th Apr 201810:23 amRNSHolding(s) in Company
5th Apr 20184:20 pmRNSDirector/PDMR Shareholding
5th Apr 20184:15 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:11 pmRNSTotal Voting Rights
29th Mar 20184:15 pmRNSDirector/PDMR Shareholding
22nd Mar 20184:00 pmRNSDirector/PDMR Shareholding
21st Mar 201810:44 amRNSHolding(s) in Company
15th Mar 20184:27 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.